Serveur d'exploration sur la COVID en France

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Optimizing lung cancer radiation treatment worldwide in COVID-19 outbreak.

Identifieur interne : 000A09 ( Main/Exploration ); précédent : 000A08; suivant : 000A10

Optimizing lung cancer radiation treatment worldwide in COVID-19 outbreak.

Auteurs : Zhongxing Liao [États-Unis] ; Eleonor Rivin Del Campo [France] ; Ahmed Salem [Royaume-Uni] ; Qingsong Pang [République populaire de Chine] ; Hui Liu [République populaire de Chine] ; Jose Luis Lopez Guerra [Espagne]

Source :

RBID : pubmed:32585497

Descripteurs français

English descriptors

Abstract

COVID-19 has spread around the planet, sending billions of people into lockdown as health services struggle to cope. Meanwhile in Asia, where the disease began, the spread continues, in China it seems for now to have passed its peak. Italy, Spain, France, UK, and the US have been the countries more affected in terms of deaths. The coronavirus is more dangerous to the elderly and those with certain pre-existing medical conditions which is precisely the profile of lung cancer patients. Essential cancer services should be delivered but all steps should be taken to protect patients and the health workforce from infection with COVID-19. This presents a major challenge to radiotherapy (RT) departments worldwide. An international panel with expertise in the management of lung cancer in high-volume comprehensive centres has come together to share its experience on COVID-19 preparedness to deliver optimal care in such exceptional circumstances. A comprehensive systematic review of the literature through a PubMed search was undertaken. Twelve recommendations including, among others, the consideration of shorter courses, delays, and the omission of RT for lung cancer are proposed by the panel. In summary, we recommend the screening of every single person accessing the treatment room, the consideration of hypofractionation and to delay postoperative RT for non-small cell lung cancer, to avoid twice-daily treatments and delay or deliver prophylactic cranial irradiation during radio(chemo)therapy for limited-stage small cell lung cancer, review image guided RT images for suspicious image findings, and the use of single-fraction RT for the palliative treatment of stage IV lung cancer patients. Given that lung cancer is one of the most common and severe pathologies in radiation oncology departments, the following recommendations require particularly urgent consideration. The decision-making paths strongly depend on locally available resources, and a tailored approach should be used to attend lung cancer patients during this pandemic.

DOI: 10.1016/j.lungcan.2020.05.029
PubMed: 32585497
PubMed Central: PMC7250079


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Optimizing lung cancer radiation treatment worldwide in COVID-19 outbreak.</title>
<author>
<name sortKey="Liao, Zhongxing" sort="Liao, Zhongxing" uniqKey="Liao Z" first="Zhongxing" last="Liao">Zhongxing Liao</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: zliao@mdanderson.org.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Rivin Del Campo, Eleonor" sort="Rivin Del Campo, Eleonor" uniqKey="Rivin Del Campo E" first="Eleonor" last="Rivin Del Campo">Eleonor Rivin Del Campo</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Radiation Oncology, Tenon University Hospital, Sorbonne University, 4 Rue de la Chine, 75020 Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Radiation Oncology, Tenon University Hospital, Sorbonne University, 4 Rue de la Chine, 75020 Paris</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Salem, Ahmed" sort="Salem, Ahmed" uniqKey="Salem A" first="Ahmed" last="Salem">Ahmed Salem</name>
<affiliation wicri:level="4">
<nlm:affiliation>Division of Cancer Sciences, University of Manchester, United Kingdom; Department of Clinical Oncology, The Christie Hospital NHS Trust, Manchester, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Division of Cancer Sciences, University of Manchester, United Kingdom; Department of Clinical Oncology, The Christie Hospital NHS Trust, Manchester</wicri:regionArea>
<placeName>
<settlement type="city">Manchester</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Manchester</region>
</placeName>
<orgName type="university">Université de Manchester</orgName>
</affiliation>
</author>
<author>
<name sortKey="Pang, Qingsong" sort="Pang, Qingsong" uniqKey="Pang Q" first="Qingsong" last="Pang">Qingsong Pang</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin</wicri:regionArea>
<placeName>
<settlement type="city">Tianjin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Liu, Hui" sort="Liu, Hui" uniqKey="Liu H" first="Hui" last="Liu">Hui Liu</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou</wicri:regionArea>
<placeName>
<settlement type="city">Jiangmen</settlement>
<region type="province">Guangdong</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lopez Guerra, Jose Luis" sort="Lopez Guerra, Jose Luis" uniqKey="Lopez Guerra J" first="Jose Luis" last="Lopez Guerra">Jose Luis Lopez Guerra</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Radiation Oncology, University Hospital Virgen del Rocío, Avda. Manuel Siurot s/n, 41013 Seville, Spain; Instituto de Biomedicina de Sevilla, Universidad de Sevilla-CSIC-Hospital Universitario V. del Rocío, Avda. Manuel Siurot s/n, 41013 Seville, Spain. Electronic address: chanodetriana@yahoo.es.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Radiation Oncology, University Hospital Virgen del Rocío, Avda. Manuel Siurot s/n, 41013 Seville, Spain; Instituto de Biomedicina de Sevilla, Universidad de Sevilla-CSIC-Hospital Universitario V. del Rocío, Avda. Manuel Siurot s/n, 41013 Seville</wicri:regionArea>
<placeName>
<region nuts="2" type="communauté">Andalousie</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32585497</idno>
<idno type="pmid">32585497</idno>
<idno type="doi">10.1016/j.lungcan.2020.05.029</idno>
<idno type="pmc">PMC7250079</idno>
<idno type="wicri:Area/Main/Corpus">000C07</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000C07</idno>
<idno type="wicri:Area/Main/Curation">000C07</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000C07</idno>
<idno type="wicri:Area/Main/Exploration">000C07</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Optimizing lung cancer radiation treatment worldwide in COVID-19 outbreak.</title>
<author>
<name sortKey="Liao, Zhongxing" sort="Liao, Zhongxing" uniqKey="Liao Z" first="Zhongxing" last="Liao">Zhongxing Liao</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: zliao@mdanderson.org.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Rivin Del Campo, Eleonor" sort="Rivin Del Campo, Eleonor" uniqKey="Rivin Del Campo E" first="Eleonor" last="Rivin Del Campo">Eleonor Rivin Del Campo</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Radiation Oncology, Tenon University Hospital, Sorbonne University, 4 Rue de la Chine, 75020 Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Radiation Oncology, Tenon University Hospital, Sorbonne University, 4 Rue de la Chine, 75020 Paris</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Salem, Ahmed" sort="Salem, Ahmed" uniqKey="Salem A" first="Ahmed" last="Salem">Ahmed Salem</name>
<affiliation wicri:level="4">
<nlm:affiliation>Division of Cancer Sciences, University of Manchester, United Kingdom; Department of Clinical Oncology, The Christie Hospital NHS Trust, Manchester, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Division of Cancer Sciences, University of Manchester, United Kingdom; Department of Clinical Oncology, The Christie Hospital NHS Trust, Manchester</wicri:regionArea>
<placeName>
<settlement type="city">Manchester</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Manchester</region>
</placeName>
<orgName type="university">Université de Manchester</orgName>
</affiliation>
</author>
<author>
<name sortKey="Pang, Qingsong" sort="Pang, Qingsong" uniqKey="Pang Q" first="Qingsong" last="Pang">Qingsong Pang</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin</wicri:regionArea>
<placeName>
<settlement type="city">Tianjin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Liu, Hui" sort="Liu, Hui" uniqKey="Liu H" first="Hui" last="Liu">Hui Liu</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou</wicri:regionArea>
<placeName>
<settlement type="city">Jiangmen</settlement>
<region type="province">Guangdong</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lopez Guerra, Jose Luis" sort="Lopez Guerra, Jose Luis" uniqKey="Lopez Guerra J" first="Jose Luis" last="Lopez Guerra">Jose Luis Lopez Guerra</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Radiation Oncology, University Hospital Virgen del Rocío, Avda. Manuel Siurot s/n, 41013 Seville, Spain; Instituto de Biomedicina de Sevilla, Universidad de Sevilla-CSIC-Hospital Universitario V. del Rocío, Avda. Manuel Siurot s/n, 41013 Seville, Spain. Electronic address: chanodetriana@yahoo.es.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Radiation Oncology, University Hospital Virgen del Rocío, Avda. Manuel Siurot s/n, 41013 Seville, Spain; Instituto de Biomedicina de Sevilla, Universidad de Sevilla-CSIC-Hospital Universitario V. del Rocío, Avda. Manuel Siurot s/n, 41013 Seville</wicri:regionArea>
<placeName>
<region nuts="2" type="communauté">Andalousie</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Lung cancer (Amsterdam, Netherlands)</title>
<idno type="eISSN">1872-8332</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Betacoronavirus (pathogenicity)</term>
<term>Carcinoma, Non-Small-Cell Lung (complications)</term>
<term>Carcinoma, Non-Small-Cell Lung (epidemiology)</term>
<term>Carcinoma, Non-Small-Cell Lung (radiotherapy)</term>
<term>Carcinoma, Non-Small-Cell Lung (virology)</term>
<term>China (epidemiology)</term>
<term>Coronavirus Infections (complications)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Coronavirus Infections (radiotherapy)</term>
<term>Coronavirus Infections (virology)</term>
<term>Disease Outbreaks (MeSH)</term>
<term>Dose Fractionation, Radiation (MeSH)</term>
<term>France (epidemiology)</term>
<term>Humans (MeSH)</term>
<term>Italy (epidemiology)</term>
<term>Palliative Care (methods)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (complications)</term>
<term>Pneumonia, Viral (epidemiology)</term>
<term>Pneumonia, Viral (radiotherapy)</term>
<term>Pneumonia, Viral (virology)</term>
<term>Small Cell Lung Carcinoma (complications)</term>
<term>Small Cell Lung Carcinoma (epidemiology)</term>
<term>Small Cell Lung Carcinoma (radiotherapy)</term>
<term>Small Cell Lung Carcinoma (virology)</term>
<term>Spain (epidemiology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Betacoronavirus (pathogénicité)</term>
<term>Carcinome pulmonaire non à petites cellules (complications)</term>
<term>Carcinome pulmonaire non à petites cellules (radiothérapie)</term>
<term>Carcinome pulmonaire non à petites cellules (virologie)</term>
<term>Carcinome pulmonaire non à petites cellules (épidémiologie)</term>
<term>Carcinome pulmonaire à petites cellules (complications)</term>
<term>Carcinome pulmonaire à petites cellules (radiothérapie)</term>
<term>Carcinome pulmonaire à petites cellules (virologie)</term>
<term>Carcinome pulmonaire à petites cellules (épidémiologie)</term>
<term>Chine (épidémiologie)</term>
<term>Espagne (épidémiologie)</term>
<term>Fractionnement de la dose d'irradiation (MeSH)</term>
<term>France (épidémiologie)</term>
<term>Humains (MeSH)</term>
<term>Infections à coronavirus (complications)</term>
<term>Infections à coronavirus (radiothérapie)</term>
<term>Infections à coronavirus (virologie)</term>
<term>Infections à coronavirus (épidémiologie)</term>
<term>Italie (épidémiologie)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (complications)</term>
<term>Pneumopathie virale (radiothérapie)</term>
<term>Pneumopathie virale (virologie)</term>
<term>Pneumopathie virale (épidémiologie)</term>
<term>Soins palliatifs (méthodes)</term>
<term>Épidémies de maladies (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>China</term>
<term>France</term>
<term>Italy</term>
<term>Spain</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Carcinoma, Non-Small-Cell Lung</term>
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
<term>Small Cell Lung Carcinoma</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Carcinoma, Non-Small-Cell Lung</term>
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
<term>Small Cell Lung Carcinoma</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Palliative Care</term>
</keywords>
<keywords scheme="MESH" qualifier="méthodes" xml:lang="fr">
<term>Soins palliatifs</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en">
<term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr">
<term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en">
<term>Carcinoma, Non-Small-Cell Lung</term>
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
<term>Small Cell Lung Carcinoma</term>
</keywords>
<keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr">
<term>Carcinome pulmonaire non à petites cellules</term>
<term>Carcinome pulmonaire à petites cellules</term>
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Carcinome pulmonaire non à petites cellules</term>
<term>Carcinome pulmonaire à petites cellules</term>
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Carcinoma, Non-Small-Cell Lung</term>
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
<term>Small Cell Lung Carcinoma</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Carcinome pulmonaire non à petites cellules</term>
<term>Carcinome pulmonaire à petites cellules</term>
<term>Chine</term>
<term>Espagne</term>
<term>France</term>
<term>Infections à coronavirus</term>
<term>Italie</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Disease Outbreaks</term>
<term>Dose Fractionation, Radiation</term>
<term>Humans</term>
<term>Pandemics</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Fractionnement de la dose d'irradiation</term>
<term>Humains</term>
<term>Pandémies</term>
<term>Épidémies de maladies</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>République populaire de Chine</term>
<term>France</term>
<term>Italie</term>
<term>Espagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">COVID-19 has spread around the planet, sending billions of people into lockdown as health services struggle to cope. Meanwhile in Asia, where the disease began, the spread continues, in China it seems for now to have passed its peak. Italy, Spain, France, UK, and the US have been the countries more affected in terms of deaths. The coronavirus is more dangerous to the elderly and those with certain pre-existing medical conditions which is precisely the profile of lung cancer patients. Essential cancer services should be delivered but all steps should be taken to protect patients and the health workforce from infection with COVID-19. This presents a major challenge to radiotherapy (RT) departments worldwide. An international panel with expertise in the management of lung cancer in high-volume comprehensive centres has come together to share its experience on COVID-19 preparedness to deliver optimal care in such exceptional circumstances. A comprehensive systematic review of the literature through a PubMed search was undertaken. Twelve recommendations including, among others, the consideration of shorter courses, delays, and the omission of RT for lung cancer are proposed by the panel. In summary, we recommend the screening of every single person accessing the treatment room, the consideration of hypofractionation and to delay postoperative RT for non-small cell lung cancer, to avoid twice-daily treatments and delay or deliver prophylactic cranial irradiation during radio(chemo)therapy for limited-stage small cell lung cancer, review image guided RT images for suspicious image findings, and the use of single-fraction RT for the palliative treatment of stage IV lung cancer patients. Given that lung cancer is one of the most common and severe pathologies in radiation oncology departments, the following recommendations require particularly urgent consideration. The decision-making paths strongly depend on locally available resources, and a tailored approach should be used to attend lung cancer patients during this pandemic.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">32585497</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>07</Month>
<Day>27</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>07</Month>
<Day>27</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1872-8332</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>146</Volume>
<PubDate>
<Year>2020</Year>
<Month>08</Month>
</PubDate>
</JournalIssue>
<Title>Lung cancer (Amsterdam, Netherlands)</Title>
<ISOAbbreviation>Lung Cancer</ISOAbbreviation>
</Journal>
<ArticleTitle>Optimizing lung cancer radiation treatment worldwide in COVID-19 outbreak.</ArticleTitle>
<Pagination>
<MedlinePgn>230-235</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0169-5002(20)30451-7</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.lungcan.2020.05.029</ELocationID>
<Abstract>
<AbstractText>COVID-19 has spread around the planet, sending billions of people into lockdown as health services struggle to cope. Meanwhile in Asia, where the disease began, the spread continues, in China it seems for now to have passed its peak. Italy, Spain, France, UK, and the US have been the countries more affected in terms of deaths. The coronavirus is more dangerous to the elderly and those with certain pre-existing medical conditions which is precisely the profile of lung cancer patients. Essential cancer services should be delivered but all steps should be taken to protect patients and the health workforce from infection with COVID-19. This presents a major challenge to radiotherapy (RT) departments worldwide. An international panel with expertise in the management of lung cancer in high-volume comprehensive centres has come together to share its experience on COVID-19 preparedness to deliver optimal care in such exceptional circumstances. A comprehensive systematic review of the literature through a PubMed search was undertaken. Twelve recommendations including, among others, the consideration of shorter courses, delays, and the omission of RT for lung cancer are proposed by the panel. In summary, we recommend the screening of every single person accessing the treatment room, the consideration of hypofractionation and to delay postoperative RT for non-small cell lung cancer, to avoid twice-daily treatments and delay or deliver prophylactic cranial irradiation during radio(chemo)therapy for limited-stage small cell lung cancer, review image guided RT images for suspicious image findings, and the use of single-fraction RT for the palliative treatment of stage IV lung cancer patients. Given that lung cancer is one of the most common and severe pathologies in radiation oncology departments, the following recommendations require particularly urgent consideration. The decision-making paths strongly depend on locally available resources, and a tailored approach should be used to attend lung cancer patients during this pandemic.</AbstractText>
<CopyrightInformation>Copyright © 2020 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Liao</LastName>
<ForeName>Zhongxing</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: zliao@mdanderson.org.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rivin Del Campo</LastName>
<ForeName>Eleonor</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, Tenon University Hospital, Sorbonne University, 4 Rue de la Chine, 75020 Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Salem</LastName>
<ForeName>Ahmed</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Division of Cancer Sciences, University of Manchester, United Kingdom; Department of Clinical Oncology, The Christie Hospital NHS Trust, Manchester, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pang</LastName>
<ForeName>Qingsong</ForeName>
<Initials>Q</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Hui</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lopez Guerra</LastName>
<ForeName>Jose Luis</ForeName>
<Initials>JL</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, University Hospital Virgen del Rocío, Avda. Manuel Siurot s/n, 41013 Seville, Spain; Instituto de Biomedicina de Sevilla, Universidad de Sevilla-CSIC-Hospital Universitario V. del Rocío, Avda. Manuel Siurot s/n, 41013 Seville, Spain. Electronic address: chanodetriana@yahoo.es.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>05</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Ireland</Country>
<MedlineTA>Lung Cancer</MedlineTA>
<NlmUniqueID>8800805</NlmUniqueID>
<ISSNLinking>0169-5002</ISSNLinking>
</MedlineJournalInfo>
<SupplMeshList>
<SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
<QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002289" MajorTopicYN="N">Carcinoma, Non-Small-Cell Lung</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004196" MajorTopicYN="Y">Disease Outbreaks</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019583" MajorTopicYN="N">Dose Fractionation, Radiation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010166" MajorTopicYN="N">Palliative Care</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D055752" MajorTopicYN="N">Small Cell Lung Carcinoma</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">COVID-19</Keyword>
<Keyword MajorTopicYN="Y">Lung cancer</Keyword>
<Keyword MajorTopicYN="Y">Outbreak</Keyword>
<Keyword MajorTopicYN="Y">Pandemic</Keyword>
<Keyword MajorTopicYN="Y">Radiation therapy</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2020</Year>
<Month>04</Month>
<Day>06</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2020</Year>
<Month>05</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2020</Year>
<Month>05</Month>
<Day>23</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>6</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>7</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>6</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32585497</ArticleId>
<ArticleId IdType="pii">S0169-5002(20)30451-7</ArticleId>
<ArticleId IdType="doi">10.1016/j.lungcan.2020.05.029</ArticleId>
<ArticleId IdType="pmc">PMC7250079</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Espagne</li>
<li>France</li>
<li>Royaume-Uni</li>
<li>République populaire de Chine</li>
<li>États-Unis</li>
</country>
<region>
<li>Andalousie</li>
<li>Angleterre</li>
<li>Grand Manchester</li>
<li>Guangdong</li>
<li>Texas</li>
<li>Île-de-France</li>
</region>
<settlement>
<li>Jiangmen</li>
<li>Manchester</li>
<li>Paris</li>
<li>Tianjin</li>
</settlement>
<orgName>
<li>Université de Manchester</li>
</orgName>
</list>
<tree>
<country name="États-Unis">
<region name="Texas">
<name sortKey="Liao, Zhongxing" sort="Liao, Zhongxing" uniqKey="Liao Z" first="Zhongxing" last="Liao">Zhongxing Liao</name>
</region>
</country>
<country name="France">
<region name="Île-de-France">
<name sortKey="Rivin Del Campo, Eleonor" sort="Rivin Del Campo, Eleonor" uniqKey="Rivin Del Campo E" first="Eleonor" last="Rivin Del Campo">Eleonor Rivin Del Campo</name>
</region>
</country>
<country name="Royaume-Uni">
<region name="Angleterre">
<name sortKey="Salem, Ahmed" sort="Salem, Ahmed" uniqKey="Salem A" first="Ahmed" last="Salem">Ahmed Salem</name>
</region>
</country>
<country name="République populaire de Chine">
<noRegion>
<name sortKey="Pang, Qingsong" sort="Pang, Qingsong" uniqKey="Pang Q" first="Qingsong" last="Pang">Qingsong Pang</name>
</noRegion>
<name sortKey="Liu, Hui" sort="Liu, Hui" uniqKey="Liu H" first="Hui" last="Liu">Hui Liu</name>
</country>
<country name="Espagne">
<region name="Andalousie">
<name sortKey="Lopez Guerra, Jose Luis" sort="Lopez Guerra, Jose Luis" uniqKey="Lopez Guerra J" first="Jose Luis" last="Lopez Guerra">Jose Luis Lopez Guerra</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A09 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000A09 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32585497
   |texte=   Optimizing lung cancer radiation treatment worldwide in COVID-19 outbreak.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32585497" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidFranceV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021